UPF0493 inhibitors represent a specialized class of chemical compounds that interact with and modulate the function of proteins from the UPF0493 family. These proteins are typically involved in various biochemical processes such as enzymatic reactions, protein interactions, or regulatory mechanisms within cells. The precise function of UPF0493 proteins may vary, but they are often characterized by unique structural domains that distinguish them from other protein families. The inhibitors of UPF0493 proteins are generally designed to bind to these active sites or regulatory regions, thereby preventing normal function and altering downstream biochemical pathways. By binding selectively to these target proteins, UPF0493 inhibitors provide valuable insights into protein function, allowing for a deeper understanding of cellular processes that rely on these proteins.
Structurally, UPF0493 inhibitors often display a diverse range of molecular configurations, depending on the target's protein structure. The chemical architecture of these inhibitors is typically optimized for specific interactions such as hydrogen bonding, van der Waals forces, and hydrophobic interactions within the active site of the UPF0493 protein. Inhibitors may contain functional groups like aromatic rings, halogen atoms, or polar substituents that enhance binding affinity and selectivity. Studying UPF0493 inhibitors also allows for the exploration of broader biochemical networks, as these inhibitors can reveal off-target interactions and cross-talk between different pathways. Overall, the study of UPF0493 inhibitors contributes to a more comprehensive understanding of cellular and molecular biology, particularly regarding the roles that UPF0493 proteins play in complex biological systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-MA could potentially decrease UPF0493 levels by inhibiting the early stages of autophagosome formation, thereby possibly leading to a reduction in UPF0493-mediated autophagy. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin may downregulate UPF0493 expression through its action as a PI3K inhibitor, disrupting the signaling required for autophagy initiation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This PI3K inhibitor could reduce the expression of UPF0493 by preventing the initiation of autophagy, which is likely to involve UPF0493 for proper autophagosome formation. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
By promoting the degradation of autophagy-related proteins, Spautin-1 could lead to a decreased presence of UPF0493, if it targets proteins for degradation associated with UPF0493. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine might reduce UPF0493's functional expression by disrupting endosomal acidification, thereby hampering the fusion of autophagosomes and lysosomes. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
This compound could inhibit UPF0493 by preventing the acidification of lysosomes, consequently disrupting autolysosome formation where UPF0493 could be essential. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Similar to Chloroquine, this compound could decrease UPF0493 expression by raising the pH in lysosomes, leading to a block in the autophagic flux that may require UPF0493 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Long-term use of Rapamycin could lead to a feedback response that reduces UPF0493 expression as part of a homeostatic reaction to sustained autophagy activation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This transcription inhibitor could directly inhibit UPF0493 synthesis by binding to DNA and halting the transcription process, leading to a reduction in mRNA levels for UPF0493. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide may decrease UPF0493 expression by blocking the translocation step in protein synthesis, leading to a halt in the production of new UPF0493 protein. | ||||||